Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...

One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...

A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

In his first term, President Donald Trump launched a bold and successful initiative against HIV. This time around, the ...

That era might now be over. In recent years, the U.S. had already begun to neglect its public-health infrastructure, ...

The bulk of the terminated grants have to do with vaccine hesitancy, HIV, Black or Latino communities and/or sex, gender and ...

"That's not science. That's ideology." -- Gregory Poland, MD, president of the Atria Health and Research Institute in New ...

Most Americans do not feel at risk for most IDs because scientific developments have mitigated their impact, said Kelley.

New study demonstrates how high-affinity B cells "bank" their best traits instead of rolling the dice and risking deleterious mutations, with implications for better vaccine design.

This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of ...

Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from a study presented at the Conference on Retroviruses and Opportunistic ...